The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhoef, A.
Right arrow Articles by Lamb, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhoef, A.
Right arrow Articles by Lamb, J. R.
The Journal of Immunology, 2000, 164: 6034-6040.
Copyright © 2000 by The American Association of Immunologists

Threshold Signaling of Human Th0 Cells in Activation and Anergy: Modulation of Effector Function by Altered TCR Ligand1

Adrienne Verhoef* and Jonathan R. Lamb2,{dagger}

* Department of Biology, Imperial College of Science, Technology and Medicine, London, United Kingdom; and {dagger} Respiratory Medicine Unit, Edinburgh University Medical School, Edinburgh, United Kingdom

Molecular interactions between TCR and its natural ligand, in the presence of costimulatory signals, elicit T cell effector functions, whereas subtle changes in the structure of antigenic peptides may induce only selected T cell effector function including anergy. In this study, we have investigated the immunological activity of an altered TCR ligand (p 2, 28–40A34,36) derived from the immunodominant T cell epitope of the group 2 allergen of house dust mite, in which residues at positions 34 and 36 were substituted by alanine. Elevated IFN-{gamma} synthesis was induced by equimolar concentrations of the analogue compared with native peptide (p 2, 28–40) and was paralleled by increased down-regulation of cell surface CD3. IL-5 and IL-10 production exhibit the same sensitivity to both peptides, implying that the induction of T cell effector functions are not all proportional to TCR occupancy. Both native peptide and the analogue bound to MHC class II (DRB1*1101) molecules with similar affinities. Furthermore, p 2, 28–40A34,36 induced T cell anergy at lower concentrations than native peptide. During the induction of anergy, TGF-ß production was comparable for both peptides, whereas IL-10 secretion was markedly increased but more so in response to p 2, 28–40A34,36. Membrane expression of costimulatory ligands CD80 and CD86 was similar for native peptide and p 2, 28–40A34,36 and increased in activation, whereas only CD86 was elevated during anergy. The modulation of T cell effector function with altered TCR ligands may have practical applications in reprogramming allergic inflammatory responses through the induction of T cell anergy and/or the promotion of Th1 cytokines.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
W. Zang, S. Kalache, M. Lin, B. Schroppel, and B. Murphy
MHC Class II-Mediated Apoptosis by a Nonpolymorphic MHC Class II Peptide Proceeds by Activation of Protein Kinase C
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3661 - 3668.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. S. Patke and D. L. Farber
Modulation of Memory CD4 T Cell Function and Survival Potential by Altering the Strength of the Recall Stimulus
J. Immunol., May 1, 2005; 174(9): 5433 - 5443.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Murphy, J. Yu, Q. Jiao, M. Lin, T. Chitnis, and M. H. Sayegh
A Novel Mechanism for the Immunomodulatory Functions of Class II MHC-Derived Peptides
J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1053 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. A. Stewart, J. A. Lowrey, S. J. Wakelin, P. M. Fitch, S. Lindey, M. J. Dallman, J. R. Lamb, and S. E. M. Howie
Sonic Hedgehog Signaling Modulates Activation of and Cytokine Production by Human Peripheral CD4+ T Cells
J. Immunol., November 15, 2002; 169(10): 5451 - 5457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.